Lantern Pharma spins out Open-Medicine AI unit to commercialize multi-agent drug discovery platformPUBT·12 hours agoLTRN-0.76%
Lantern Pharma (Nasdaq: LTRN) Establishes Open-Medicine AI as a Separate Company to Commercialize and Expand Its Multi-Agent AI Co-Scientist Platform for the Transformation of Medicine | LTRN Stock NewsStockTitan·20 hours agoLTRN-0.76%
New to The Street TV Announces Broadcast of Show No. 765 Tonight on Bloomberg Television at 6:30 PM ET Featuring Envoy Medical, Graphene Manufacturing Group, Rhino Bitcoin, and Big Sky IndustrialMorningStar·2 days ago, 10:38 AMDVLT+4.79%BSIN-0.88%
Lantern Pharma to Advance EMA-Cleared Phase 1b/2 Trial of LP-184 (Zirdafulven) in Biomarker-Selected Advanced Bladder Cancer | LTRN Stock NewsStockTitan·Jul 27 at 10:45 PMLTRN-0.76%
Lantern Pharma Receives USPTO Notice of Allowance for Patent Covering Biomarker-Guided Treatment with LP-184 (Zirdafulven) in Multiple Solid Tumor Cancers | LTRN Stock NewsStockTitan·Jul 22 at 11:01 PMLTRN-0.76%
New to The Street(R) to Broadcast Show #762 Tonight on Bloomberg Television at 6:30 PM ET, Featuring Envoy Medical (NASDAQ:COCH), AlphaCompute (NASDAQ:ALP), RHINO Bitcoin (OTC PINK:RHNO), and Big Sky Industrial (NASDAQ:BSIN)MorningStar·Jul 18 at 12:03 PMBSIN-0.88%COCH+2.97%
Lantern Pharma publishes investor presentation on AI-driven oncology drug development platform, pipeline programsPUBT·Jul 13 at 03:39 PMLTRN-0.76%
Lantern Pharma Launches ZetaOmics™ — an Autonomous, Intelligent “Computational Biologist” That Brings Expert-Grade Bioinformatics, Biostatistics & Reasoning to Every Cancer | LTRN Stock NewsStockTitan·Jul 7 at 10:30 PMLTRN-0.76%
